Chemoimmunotherapy in Metastatic Urothelial Carcinoma

Eur Urol. 2018 May;73(5):760-762. doi: 10.1016/j.eururo.2017.12.029. Epub 2018 Jan 10.

Authors

Daniel M Geynisman¹, Phillip H Abbosh², Elizabeth R Plimack³, Matthew Zibelman³

Affiliations

¹ Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA. Electronic address: daniel.geynisman@fccc.edu.
² Molecular Therapeutics, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA; Department of Urology, Einstein Medical Center, Philadelphia, PA, USA.
³ Hematology/Oncology, Fox Chase Cancer Center, Temple Health, Philadelphia, PA, USA.

PMID: 29331216
DOI: 10.1016/j.eururo.2017.12.029

No abstract available

Publication types

Editorial
Comment

MeSH terms

Carcinoma, Transitional Cell*
Humans
Immunotherapy
Urinary Bladder Neoplasms
Urologic Neoplasms*